EpyDiagnosis is a pioneering company that combines artificial intelligence with data analysis to revolutionize early lung cancer diagnosis. We are dedicated to offering innovative solutions that facilitate early diagnosis and optimize treatment. Our story begins with a commitment to closing the gap in lung healthcare, making advanced technology accessible to healthcare professionals in resource-limited settings.
The foundational principles of EpyDiagnosis focus on saving and improving lives through advanced and accessible AI solutions for lung cancer diagnosis. We strive to empower healthcare professionals with accurate and user-friendly tools, ensuring patients receive timely diagnoses.
Lung Cancer: A Global Challenge, A Local Emergency
Lung cancer stands as a leading cause of cancer deaths globally, accounting for 18.2% of fatalities due to late detection and poor prognosis in advanced stages. In Mexico, the challenge intensifies with less than 1% of cases caught early, stressing both the healthcare system and the economy with high treatment costs.
EpyDiagnosis confronts this urgency with AI-driven innovation, targeting the enhancement of early detection to shift outcomes. As the demand for precise diagnostics grows, our strategy focuses on equipping Mexican health institutions with the tools to combat this pervasive disease, envisioning a future with improved survival rates and sustainable healthcare practices.
Top Non-Communicable Disease Causes of Death Worldwide (WHO)
MORTALITY BY PRIMARY TUMOR SITE (GLOBOCAN, 2020)
MEXICO DEATHS DUE TO MALIGNANT TUMORS (INEGI, 2021)
The heart of EpyDiagnosis is its sophisticated AI algorithm, which has been rigorously validated with data from the Mexican Social Security Institute (IMSS). It’s not just about recognizing patterns in imaging data; it’s about providing a nuanced interpretation that mirrors the expertise of a seasoned radiologist. This AI enhancement promises to alleviate the burden on healthcare systems by reducing both diagnostic times and error rates, paving the way for more effective treatment and management of lung cancer patients.
Moreover, EpyDiagnosis is designed with the end-user in mind, offering seamless integration into existing hospital systems through a user-friendly API. This ensures that our solution enhances, rather than disrupts, the workflow of medical professionals. With EpyDiagnosis, radiologists, oncologists, and other healthcare providers receive a powerful ally in the fight against one of the deadliest forms of cancer, directly contributing to better patient outcomes and optimized healthcare resources.
Our Research Areas
At the core of our research is the integration of Data Science and Artificial Intelligence (AI), deploying innovative algorithms and advanced neural networks for medical data analysis and precise diagnostics. In Personalized Medicine, we focus on therapies tailored to individual genetic and molecular profiles. Cancer Detection benefits from our AI techniques, identifying the disease in its early stages. In Treatment, we explore new therapeutic modalities to improve patient outcomes. Additionally, we delve into Deep Language Processing in Medicine, aiming to enhance communication and understanding in healthcare.
Collaboration and Participation
At EpyDiagnosis, we highly value the donation of documented clinical cases, crucial for enhancing our distributed data networks and AI solutions. Embracing standards like OHDSI for secure and effective collaboration, we invite researchers and students to join us in advancing personalized medicine and developing more accurate treatments.
Newsletter Updates
Subscribing to EpyDiagnosis’ «Newsletter Updates» is crucial for staying informed about the latest in personalized medicine and health technology. This platform not only keeps you updated on breakthroughs and discoveries but also fosters an engaged community interested in the future of healthcare. Stay connected with the newest insights and news from EpyDiagnosis, delivered straight to your inbox.